IBDEI1J5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24764,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,24764,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,24765,0)
 ;;=F11.90^^85^1090^19
 ;;^UTILITY(U,$J,358.3,24765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24765,1,3,0)
 ;;=3^Opioid Use,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,24765,1,4,0)
 ;;=4^F11.90
 ;;^UTILITY(U,$J,358.3,24765,2)
 ;;=^5003142
 ;;^UTILITY(U,$J,358.3,24766,0)
 ;;=Z79.891^^85^1090^1
 ;;^UTILITY(U,$J,358.3,24766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24766,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,24766,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,24766,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,24767,0)
 ;;=M15.8^^85^1091^51
 ;;^UTILITY(U,$J,358.3,24767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24767,1,3,0)
 ;;=3^Polyosteoarthritis,Other
 ;;^UTILITY(U,$J,358.3,24767,1,4,0)
 ;;=4^M15.8
 ;;^UTILITY(U,$J,358.3,24767,2)
 ;;=^5010767
 ;;^UTILITY(U,$J,358.3,24768,0)
 ;;=F07.0^^85^1091^41
 ;;^UTILITY(U,$J,358.3,24768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24768,1,3,0)
 ;;=3^Personality Change d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,24768,1,4,0)
 ;;=4^F07.0
 ;;^UTILITY(U,$J,358.3,24768,2)
 ;;=^5003063
 ;;^UTILITY(U,$J,358.3,24769,0)
 ;;=G62.9^^85^1091^50
 ;;^UTILITY(U,$J,358.3,24769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24769,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,24769,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,24769,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,24770,0)
 ;;=F43.10^^85^1091^1
 ;;^UTILITY(U,$J,358.3,24770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24770,1,3,0)
 ;;=3^PTSD Unspec
 ;;^UTILITY(U,$J,358.3,24770,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,24770,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,24771,0)
 ;;=F43.12^^85^1091^2
 ;;^UTILITY(U,$J,358.3,24771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24771,1,3,0)
 ;;=3^PTSD,Chr
 ;;^UTILITY(U,$J,358.3,24771,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,24771,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,24772,0)
 ;;=G20.^^85^1091^39
 ;;^UTILITY(U,$J,358.3,24772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24772,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,24772,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,24772,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,24773,0)
 ;;=I73.9^^85^1091^3
 ;;^UTILITY(U,$J,358.3,24773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24773,1,3,0)
 ;;=3^PVD,Unspecified
 ;;^UTILITY(U,$J,358.3,24773,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,24773,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,24774,0)
 ;;=I80.3^^85^1091^46
 ;;^UTILITY(U,$J,358.3,24774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24774,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis Lower Extremities,Unspec
 ;;^UTILITY(U,$J,358.3,24774,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,24774,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,24775,0)
 ;;=J02.9^^85^1091^42
 ;;^UTILITY(U,$J,358.3,24775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24775,1,3,0)
 ;;=3^Pharyngitis Acute,Unspec
 ;;^UTILITY(U,$J,358.3,24775,1,4,0)
 ;;=4^J02.9
 ;;^UTILITY(U,$J,358.3,24775,2)
 ;;=^5008130
 ;;^UTILITY(U,$J,358.3,24776,0)
 ;;=J18.9^^85^1091^49
 ;;^UTILITY(U,$J,358.3,24776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24776,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,24776,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,24776,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,24777,0)
 ;;=R09.1^^85^1091^48
